Colorectal cancer is the second most common cause of cancer-related death in Europe and the United States. Several studies have evaluated the immune response to colorectal cancer, with contradictory results. Some studies showed that lymphocyte infiltration in colorectal cancer seemed to be an important prognostic parameter, a finding not confirmed by other studies. Several studies showed the gamma-delta T-cell receptor repertoire of intestinal adenocarcinoma. In this study, we hypothesize that the presence of T cells with the T-cell receptor gamma complex may play a particular role in carcinogenesis and tumor progression.
Methods
A total of 58 patients with colon adenocarcinoma was included in the analysis. We used the TNM staging system to grade colon cancer.
Results
Thirty samples (52.6%) revealed a polyclonal rearrangement of T-cell receptor gamma. In the N0 cases, only 5 samples revealed a T-cell receptor gamma molecular assessment; in N1/N2 cases, 25 revealed a T-cell receptor gamma molecular assessment.
Conclusions
The results showed statistical significance between the presence of T-cell receptor gamma and N1/N2 stage lymph nodes (P = 0.001).
International Agency for Research on Cancer (IARC):Pathology and Genetics of Tumours of the Digestive System. In: World Health Organization Classification of Tumors,KleihuesP., SobinL.H. (Eds), pp 105–106, IARC press, Lyon, 2000.
2.
SheehanK.M., O'ConnellF., O'GradyA., ConroyR.M., LeaderM.B., ByrneM.F., MurrayF.E., KayE.W.: The relationship between cyclooxygenase-2 expression and characteristics of malignant transformation in human colorectal adenomas.Eur J Gastroenterol Hepatol, 16: 619–625, 2004.
3.
NaitoY., SaitoK., ShiibaK., OhuchiA., SaigenjiK., NaguraH., OhtaniH.: CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.Cancer Res, 58: 3491–3494, 1998.
MulderW.M., StukartM.J., de WindtE., WagstaffJ., ScheperR.J., BloemenaE.: Mucin-1-related T cell infiltration in colorectal carcinoma.Cancer Immunol Immunother, 42: 351–356, 1996.
6.
DunnG.P., BruceA.T., IkedaH., OldL.J., SchreiberR.D.: Cancer immunoediting: from immunosurveillance to tumor escape.Nat Immunol, 3: 991–998, 2002.
7.
MarrogiA.J., MunshiA., MerogiA.J., OhadikeY., El-HabashiA., MarrogiO.L., FreemanS.M.: Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma.Int J Cancer, 74: 492–501, 1997.
8.
NakanoO., SatoM., NaitoY., SuzukiK., OrikasaS., AizawaM., SuzukiY., ShintakuI., NaguraH., OhtaniH.: Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity.Cancer Res, 61: 5132–5136, 2001.
BrennerM.B., StromingerJ.L., KrangelM.S.: The gamma delta T cell receptor.Adv Immunol, 43: 133–192, 1988.
11.
MombaertsP., ArnoldiJ., RussF., TonegawaS., KaufmannS.H.: Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen.Nature, 365: 53–56, 1993.
12.
GirardiM., OppenheimD.E., SteeleC.R., LewisJ.M., GlusacE., FillerR., HobbyP., SuttonB., TigelaarR.E., HaydayA.C.: Regulation of cutaneous malignancy by gamma delta T cells.Science, 294: 605–609, 2001.
13.
IkeguchiM., OiK., HirookaY., KaibaraN.: CD8+ lymphocyte infiltration and apoptosis in hepatocellular carcinoma.Eur J Surg Oncol, 30: 53–57, 2004.
14.
VesalainenS., LipponenP., TaljaM., SyrjanenK.: Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma.Eur J Cancer, 30A: 1797–1803, 1994.
15.
RaspolliniM.R., CastiglioneF., Rossi Degl'innocentiD., AmunniG., VillanucciA., GarbiniF., BaroniG., TaddeiG.L.: Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma.Ann Oncol, 16: 590–596, 2005.
16.
OliveC., NicolD., FalkM.C.: Characterisation of gamma delta T cells in renal cell carcinoma patients by polymerase chain reaction analysis of T cell receptor transcripts.Cancer Immunol Immunother, 44: 27–34, 1997.
17.
SpadaF.M., GrantE.P., PetersP.J., SugitaM., MelianA., LeslieD.S., LeeH.K., van DonselaarE., HansonD.A., KrenskyA.M., MajdicO., PorcelliS.A., MoritaC.T., BrennerM.B.: Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity.J Exp Med, 191: 937–948, 2000.
18.
SmythM.J., TrapaniJ.A.: Lymphocyte-mediated immunosurveillance of epithelial cancers?Trends Immunol,22: 409–411, 2001.
19.
McCarthyK.P., SloaneJ.P., KabarowskiJ.H., MatutesE., WiedemannL.M.: The rapid detection of clonal T-cell proliferations in patients with lymphoid disorders.Am JPathol, 138: 821–828, 1991.
20.
Van Ravenswaay ClaasenH.H., KluinP.M., FleurenG.J.: Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity.Lab Invest, 67: 166–174, 1992.
21.
SantinA.D., HermonatP.L., RavaggiA., BelloneS., RomanJ.J., SmithC.V., PecorelliS., Radominska-PandyaA., CannonM.J., ParhamG.P.: Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.Gynecol Obstet Invest, 51: 254261, 2001.
22.
CoulieP.G., KaranikasV., ColauD., LurquinC., LandryC., MarchandM., DorvalT., BrichardV., BoonT.: A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.Proc Natl Acad Sci USA, 98: 10290–10295, 2001.
